U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07388628) titled 'ARTICE(R) Real Data Collection & Observational Trial, Phase 4 Study' on Jan. 05.
Brief Summary: The objectives of this registry study are to:
1. Record real-life data related to the use of the ARTICE(R) therapy in sepsis subjects.
2. Further evaluate ARTICE(R) treatment efficacy.
3. Identify potential sub-groups, assess their risk-benefit- and safety profile.
4. Changes in SOFA score D0 to SOFA Score D7.
Study Start Date: Sept. 25, 2025
Study Type: OBSERVATIONAL
Condition:
Sepsis
Septic Shock
Immunoparalysis in Septic Shock
Recruitment Status: RECRUITING
Sponsor: Artcline GmbH
Published by HT Digital Content Services with ...